Clinical trial
Efficacy and Safety of Denosumab Compared With Risedronate in Individuals Taking…
NCT01575873 · Amgen, Industry · Completed
Key facts
| NCT number | NCT01575873 |
|---|---|
| Title | Efficacy and Safety of Denosumab Compared With Risedronate in Individuals Taking Glucocorticoids |
| Official title | A Randomized, Double-blind, Active-controlled Study to Evaluate the Efficacy and Safety of Denosumab Compared With Risedronate in Glucocorticoid-treated Individuals |
| Acronym | GIOP |
| Lead sponsor | Amgen, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Steroid-induced Osteopor, Glucocorticoid-induced Ostepor |
| Intervention type | Drug |
| Interventions | Denosumab, Placebo for risendronate, Risendronate, Placebo for denosumab |
| Enrollment | 795 |
| Start date | Mar 28, 2012 |
| Primary completion | Jun 21, 2016 |
| Completion | Jun 29, 2017 |
| First posted | Apr 12, 2012 |
| Last update posted | Jul 27, 2018 |
| Countries | Argentina, Belgium, Canada, Colombia, Czechia, Denmark, France, Germany, Hungary, Mexico, Netherlands, Poland and 4 more |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: